VAERS reports by lot

Pfizer COVID-19 lot EWO172: VAERS reports

60 VAERS reports list lot EWO172 as a Pfizer COVID-19 vaccine, received between 2021-04-27 and 2022-08-11. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
60
Reports
15%
Marked serious
1
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)5324%
Neurological4319%
Cardiac / Cardiovascular2913%
Musculoskeletal2612%
Gastrointestinal188%
Respiratory136%
Allergic / Anaphylactic125%
Injection-site / Local reaction125%
Dermatological (non-injection-site)84%
Thrombotic / Hematological42%
Psychiatric / Neuropsychiatric42%
Autoimmune / Immune-mediated10%
Reproductive / Menstrual10%

Where reports came from

U.S. state of the reporter, where given (top 12).

California9
Kentucky8
Michigan6
Indiana6
Illinois4
New York3
District of Columbia2
New Hampshire2
Massachusetts2
Florida2
Ohio2
Minnesota1

Reports by month received

2021-044
2021-0517
2021-064
2021-073
2021-085
2021-095
2021-1014
2021-112
2021-121
2022-021
2022-033
2022-081

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.